Lake Street raised the firm’s price target on Sight Sciences (SGHT) to $3 from $2.50 and keeps a Hold rating on the shares. The firm, which believes Q1 highlights stabilization in the face of MIGS LCD pressures, continues to see potential for reacceleration in 2026 and thinks shares are likely trading near a trough multiple, but also believes broader payer progress on TearCare and normalized MIGS procedure volumes will be required to support growth acceleration.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SGHT: